Similarly, the delivery of the anti-tumour hIL-15 cytokine using the rAAV2-hIL15 led to the inhibition of growth in HeLa cells in vitro and in vivo in murine models [116], while rAAV2-LIGHT, an AAV vector carrying LIGHT, a TNF ligand, succeeded in suppressing tumorigenesis in a murine cervical cancer model [117]. Here, TNFSF14 is linked to cervical carcinoma.